ArticleInternational journal of molecular sciences2022

Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal Cancer.

Zixuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.